Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.485
Delayed Data
As of Jun 23
 -0.005 / -1.02%
Today’s Change
0.39
Today|||52-Week Range
2.64
-29.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues15.0K22.0K16.0K84.0K
 
 
 
 
 
Cost of Goods Sold163.0K105.5K116.0K133.0K
 
 
 
 
 
Depreciation And Amortization316.0K333.0K324.0K274.0K
 
 
 
 
 
 
Operating ExpensesGross Income-464.0K-416.5K-424.0K-323.0K
 
 
 
 
 
General Expenses2.4M2.8M3.7M2.9M
 
 
 
 
 
Research And Development900.0K1.3M1.9M1.4M
 
 
 
 
 
Total Operating Expenses2.9M3.2M4.1M3.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.8M-3.2M-4.1M-3.2M
 
 
 
 
 
Extraordinary Credit1.5M293.0K1.6M393.0K
 
 
 
 
 
Other Expenses20.0K31.0K1.3M1.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.3M-2.9M-1.2M-2.8M
 
 
 
 
 
Net Income-1.3M-2.9M-1.2M-2.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS20.7M21.8M24.2M25.3M
 
 
 
 
 
Shares To Calculate EPS Diluted20.7M21.8M24.2M25.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12-$0.13-$0.04-$0.11
 
 
 
 
 
EPS Diluted-$0.12-$0.13-$0.05-$0.11